Seeing Is Believing
Currently out of the existing stock ratings of Jason Mills, 28 are a HOLD (13.46%), 178 are a BUY (85.58%), 2 are a SELL (0.96%).
Analyst Jason Mills, carries an average stock price target met ratio of 84.21% that have a potential upside of 23.17% achieved within 313 days. Previously, Jason Mills worked at CANACCORD, TD COWEN.
Jason Mills’s has documented 447 price targets and ratings displayed on 25 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on PEN, Penumbra at 20-Jan-2026.
Analyst best performing recommendations are on ELGX (ENDOLOGIX).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 3/5/2020. The price target of $112 was fulfilled within 11 days with a profit of $30.8 (37.93%) receiving and performance score of 34.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Jul-2026
$48
$5.4 (12.68%)
$50
9 days ago
(24-Sep-2026)
18/25 (72%)
$3.32 (7.43%)
226
Buy Since 16-Jan-2026
$65
$22.4 (52.58%)
$85
12 days ago
(21-Sep-2026)
0/4 (0%)
$21.28 (48.67%)
Buy Since 25-Apr-2019
$50
$7.4 (17.37%)
$61
16 days ago
(17-Sep-2026)
21/31 (67.74%)
$6.45 (14.81%)
267
Buy Since 06-Feb-2020
$56
$13.4 (31.46%)
$60
24 days ago
(09-Sep-2026)
20/36 (55.56%)
$11.04 (24.56%)
259
Buy Since 06-Dec-2013
$56
$13.4 (31.46%)
$56
1 months 8 days ago
(25-Aug-2026)
24/38 (63.16%)
$6.14 (12.31%)
329